BioXcel Therapeutics BTAIQ
OTC BTAIQ
$0.01 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

BioXcel Therapeutics (BTAIQ) Notes Payables (2017)

Updated

BioXcel Therapeutics' Notes Payables was $371,000 in Q4 2017.

Analysis

BioXcel Therapeutics (BTAIQ) Notes Payables (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 BioXcel Therapeutics 313,049.99 -94.30 Mn 160,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 371,000.00
API Access

BioXcel Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY